Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1881.33 | 4026.00 | 3831.50 | 1.0508 | 1.0989 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 3629.00 | 3831.50 | 0.9472 | 0.8969 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 2500.00 | 1881.33 | 3873.00 | 3831.50 | 1.0108 | 1.0211 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 4151.00 | 3831.50 | 1.0834 | 1.1624 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 2.00 | 3831.50 | 0.0005 | -0.9987 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 11.00 | 3831.50 | 0.0029 | -0.9933 | |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3586.00 | 3831.50 | 0.9359 | 0.8750 | |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2945.00 | 3831.50 | 0.7686 | 0.5476 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 3817.00 | 3831.50 | 0.9962 | 0.9926 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2013.00 | 3831.50 | 0.5254 | 0.0681 |
| SK-BR-3 | 17-AAG | 0.0016596 | uM | 7 | 2500.00 | 1881.33 | 3515.00 | 3831.50 | 0.9174 | 0.8388 |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 2500.00 | 1881.33 | 1893.00 | 3831.50 | 0.4941 | 0.0060 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 2500.00 | 1881.33 | 3756.00 | 3831.50 | 0.9803 | 0.9616 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 2164.00 | 3831.50 | 0.5648 | 0.1462 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3958.00 | 3831.50 | 1.0330 | 1.0643 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 2500.00 | 1881.33 | 2430.00 | 3831.50 | 0.6342 | 0.2832 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 2500.00 | 1881.33 | 2557.00 | 3831.50 | 0.6674 | 0.3486 |
| SK-BR-3 | 0 | uM | 7 | 2500.00 | 1881.33 | 3775.00 | 3831.50 | 0.9853 | 0.9713 | |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2208.00 | 3831.50 | 0.5763 | 0.1689 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 7 | 2500.00 | 1881.33 | 4106.00 | 3831.50 | 1.0716 | 1.1395 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 2500.00 | 1881.33 | 2037.00 | 3831.50 | 0.5317 | 0.0806 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 2500.00 | 1881.33 | 2483.00 | 3831.50 | 0.6481 | 0.3105 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1881.33 | 3866.00 | 3831.50 | 1.0090 | 1.0175 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 2500.00 | 1881.33 | 4082.00 | 3831.50 | 1.0654 | 1.1273 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 2500.00 | 1881.33 | 2195.00 | 3831.50 | 0.5729 | 0.1622 |